{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:11:40Z","timestamp":1788783100736,"version":"build-2803163510"},"reference-count":43,"publisher":"American Chemical Society (ACS)","issue":"9","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010276","name":"Society of Iodine Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003844","name":"Inamori Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019433","name":"Shibuya Science Culture and Sports Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019433","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K07812"],"award-info":[{"award-number":["JP22K07812"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K22607"],"award-info":[{"award-number":["JP25K22607"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008884","name":"Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hokuriku Bank"},{"name":"Pharmaceutical Sciences Research Foundation"},{"name":"Hokkoku Cancer Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In Auger electron therapy, the effective delivery of Auger electron-emitting radionuclides to the nuclei of cancer cells is essential for achieving high therapeutic efficacy. In this study, we developed a novel strategy that combined thermosensitive liposomes (TSLs) encapsulating 125I-labeled DNA-targeted compounds. This approach enabled enhanced tumor accumulation via TSL-mediated delivery and efficient nuclear translocation of radioactivity by releasing an 125I-labeled doxorubicin derivative ([125I]I-DOX) within the tumor microenvironment. [125I]I-DOX exhibited high cellular and nuclear uptake, producing potent cytotoxicity through Auger electrons emitted from 125I. [125I]I-DOX-loaded TSLs efficiently released [125I]I-DOX at 43 \u00b0C, enhancing its cellular uptake by Colon-26 cells. Tumor accumulation of radioactivity in the heating group was much higher than in the nonheating group, and the accumulation was maintained for up to 48 h postinjection. Intravenous injection of [125I]I-DOX-loaded TSLs (5.0 MBq) and localized tumor heating significantly inhibited tumor growth without body weight loss. The combination of [125I]I-DOX-loaded TSLs and hyperthermia represents a promising strategy for Auger electron therapy targeting the nuclei of cancer cells.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.6c00443","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:00:06Z","timestamp":1785128406000},"page":"4681-4689","source":"Crossref","is-referenced-by-count":0,"title":["Auger\nElectron Therapy Enhanced by Heat-Triggered\nRelease of I-125-Labeled DNA-Targeted Compounds within the\nTumor Microenvironment"],"prefix":"10.1021","volume":"23","author":[{"given":"Masayuki","family":"Munekane","sequence":"first","affiliation":[{"name":"Kanazawa University , , Kakuma-machi , ,","place":["Kanazawa, Japan, 920-1192"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Matsunaga","sequence":"additional","affiliation":[{"name":"Kanazawa University , , Kakuma-machi , ,","place":["Kanazawa, Japan, 920-1192"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Kanazawa University , , Kakuma-machi , ,","place":["Kanazawa, Japan, 920-1192"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Echigo","sequence":"additional","affiliation":[{"name":"Kanazawa University , , Kakuma-machi , ,","place":["Kanazawa, Japan, 920-1192"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5071-7574","authenticated-orcid":true,"given":"Kenji","family":"Mishiro","sequence":"additional","affiliation":[{"name":"Kanazawa University , , Kakuma-machi , ,","place":["Kanazawa, Japan, 920-1192"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8141-1212","authenticated-orcid":true,"given":"Takeshi","family":"Fuchigami","sequence":"additional","affiliation":[{"name":"Kanazawa University , , Kakuma-machi , ,","place":["Kanazawa, Japan, 920-1192"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1691-7302","authenticated-orcid":true,"given":"Kazuma","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Kanazawa University , , Kakuma-machi , ,","place":["Kanazawa, Japan, 920-1192"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"7","key":"2026090707080285300_cit1","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.7150\/thno.96403","article-title":"Actinium-225 targeted alpha particle therapy for prostate\ncancer","volume":"14","author":"Bidkar","year":"2024","journal-title":"Theranostics"},{"issue":"7","key":"2026090707080285300_cit2","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s00259-024-06719-5","article-title":"Can current preclinical\nstrategies for radiopharmaceutical development meet the needs of targeted\nalpha therapy?","volume":"51","author":"Kleynhans","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2026090707080285300_cit3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ccr.2018.12.005","article-title":"Radiotheranostics with\nradiolanthanides: Design, development strategies, and medical applications","volume":"383","author":"Mishiro","year":"2019","journal-title":"Coord. Chem. Rev."},{"issue":"9","key":"2026090707080285300_cit4","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1248\/cpb.c19-00274","article-title":"Development\nof Diagnostic and Therapeutic Probes with Controlled Pharmacokinetics\nfor Use in Radiotheranostics","volume":"67","author":"Ogawa","year":"2019","journal-title":"Chem. Pharm. Bull."},{"issue":"14","key":"2026090707080285300_cit5","doi-asserted-by":"publisher","first-page":"11626","DOI":"10.3390\/ijms241411626","article-title":"Targeted Alpha-Particle Therapy:\nA Review of Current\nTrials","volume":"24","author":"Jang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"2026090707080285300_cit6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s41181-024-00298-4","article-title":"Astatine-211 radiolabelling chemistry:\nfrom basics to advanced biological applications","volume":"9","author":"Vanermen","year":"2024","journal-title":"EJNMMI Radiopharm Chem."},{"issue":"5","key":"2026090707080285300_cit7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s44211-024-00514-w","article-title":"Recent advances in the development\nof 225Ac- and 211At-labeled radioligands for\nradiotheranostics","volume":"40","author":"Munekane","year":"2024","journal-title":"Anal. Sci."},{"issue":"9","key":"2026090707080285300_cit8","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1248\/bpb.b25-00195","article-title":"Probes with Tailored\nPharmacokinetics for Radiotheranostics","volume":"48","author":"Munekane","year":"2025","journal-title":"Biol.\nPharm. Bull."},{"key":"2026090707080285300_cit9","doi-asserted-by":"publisher","first-page":"218173","DOI":"10.1016\/j.ccr.2026.218173","article-title":"Radiotheranostics with high-LET \u03b1-particle\nand auger Electron emitters: A coordination chemistry perspective","volume":"566","author":"Munekane","year":"2026","journal-title":"Coord. Chem. Rev."},{"issue":"23","key":"2026090707080285300_cit10","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.3390\/cancers14235792","article-title":"A Clinical Guide to Peptide Receptor\nRadionuclide Therapy with 177Lu-DOTATATE in Neuroendocrine\nTumor Patients","volume":"14","author":"Becx","year":"2022","journal-title":"Cancers"},{"issue":"10","key":"2026090707080285300_cit11","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3390\/ph15101292","article-title":"177Lu]Lu-PSMA-617 (Pluvicto(TM)): The First FDA-Approved\nRadiotherapeutical for Treatment of Prostate Cancer","volume":"15","author":"Hennrich","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"12","key":"2026090707080285300_cit12","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.2967\/jnumed.116.178673","article-title":"225Ac-PSMA-617 for PSMA-Targeted\nalpha-Radiation Therapy of Metastatic Castration-Resistant Prostate\nCancer","volume":"57","author":"Kratochwil","year":"2016","journal-title":"J. Nucl. Med."},{"issue":"5","key":"2026090707080285300_cit13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1053\/j.semnuclmed.2019.06.002","article-title":"From Bench\nto Bedside-The\nBad Berka Experience With First-in-Human Studies","volume":"49","author":"Zhang","year":"2019","journal-title":"Semin. Nucl. Med."},{"key":"2026090707080285300_cit14","doi-asserted-by":"publisher","first-page":"1034315","DOI":"10.3389\/fmed.2022.1034315","article-title":"Alpha-peptide receptor radionuclide\ntherapy using actinium-225 labeled somatostatin receptor agonists\nand antagonists","volume":"9","author":"Shi","year":"2022","journal-title":"Front Med."},{"issue":"1","key":"2026090707080285300_cit15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s41181-019-0075-2","article-title":"Auger electrons\nfor cancer therapy - a review","volume":"4","author":"Ku","year":"2019","journal-title":"EJNMMI Radiopharm\nChem."},{"key":"2026090707080285300_cit16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.nucmedbio.2021.03.002","article-title":"Auger: The\nfuture of precision medicine","volume":"96\u201397","author":"Pirovano","year":"2021","journal-title":"Nucl. Med. Biol."},{"issue":"9","key":"2026090707080285300_cit17","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.2967\/jnumed.122.265039","article-title":"Marshalling the Potential of Auger\nElectron Radiopharmaceutical\nTherapy","volume":"64","author":"Bolcaen","year":"2023","journal-title":"J. Nucl. Med."},{"key":"2026090707080285300_cit18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.addr.2015.12.003","article-title":"Radioimmunotherapy\nof cancer with\nhigh linear energy transfer (LET) radiation delivered by radionuclides\nemitting alpha-particles or Auger electrons","volume":"109","author":"Aghevlian","year":"2017","journal-title":"Adv. Drug Deliv Rev."},{"issue":"12","key":"2026090707080285300_cit19","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1080\/09553000802395535","article-title":"First human treatment of resistant neoplastic meningitis\nby intrathecal administration of MTX plus 125IUdR","volume":"84","author":"Rebischung","year":"2008","journal-title":"Int. J. Radiat. Biol."},{"issue":"11","key":"2026090707080285300_cit20","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3390\/ph16111526","article-title":"Novel Auger-Electron-Emitting 191Pt-Labeled Pyrrole-Imidazole Polyamide Targeting MYCN Increases\nCytotoxicity and Cytosolic dsDNA Granules in MYCN-Amplified Neuroblastoma","volume":"16","author":"Obata","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"6","key":"2026090707080285300_cit21","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.nucmedbio.2006.06.002","article-title":"A novel 125I-labeled daunorubicin\nderivative for radionuclide-based\ncancer therapy","volume":"33","author":"Ickenstein","year":"2006","journal-title":"Nucl. Med. Biol."},{"issue":"12","key":"2026090707080285300_cit22","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.2967\/jnumed.123.265429","article-title":"[123I]CC1: A PARP-Targeting, Auger\nElectron-Emitting Radiopharmaceutical for Radionuclide Therapy of\nCancer","volume":"64","author":"Chan","year":"2023","journal-title":"J. Nucl. Med."},{"key":"2026090707080285300_cit23","doi-asserted-by":"publisher","first-page":"108368","DOI":"10.1016\/j.nucmedbio.2023.108368","article-title":"Preclinical\nstudies of a PARP targeted, Meitner-Auger\nemitting, theranostic radiopharmaceutical for metastatic ovarian cancer","volume":"122\u2013123","author":"Hoffman","year":"2023","journal-title":"Nucl. Med. Biol."},{"issue":"8","key":"2026090707080285300_cit24","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2967\/jnumed.106.037937","article-title":"111In-labeled trastuzumab\n(Herceptin) modified with nuclear localization\nsequences (NLS): an Auger electron-emitting radiotherapeutic agent\nfor HER2\/neu-amplified breast cancer","volume":"48","author":"Costantini","year":"2007","journal-title":"J. Nucl.\nMed."},{"issue":"5","key":"2026090707080285300_cit25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.nucmedbio.2014.02.003","article-title":"The human polynucleotide\nkinase\/phosphatase\n(hPNKP) inhibitor A12B4C3 radiosensitizes human myeloid leukemia cells\nto Auger electron-emitting anti-CD123 111In-NLS-7G3 radioimmunoconjugates","volume":"41","author":"Zereshkian","year":"2014","journal-title":"Nucl. Med. Biol."},{"key":"2026090707080285300_cit26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jconrel.2022.08.001","article-title":"Stimuli-responsive liposomal nanoformulations\nin cancer therapy: Pre-clinical & clinical approaches","volume":"351","author":"Ashrafizadeh","year":"2022","journal-title":"J. Controlled Release"},{"issue":"5","key":"2026090707080285300_cit27","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3390\/polym14050925","article-title":"Thermosensitive\nPolymers and Thermo-Responsive Liposomal Drug Delivery Systems","volume":"14","author":"Abuwatfa","year":"2022","journal-title":"Polymers"},{"issue":"53","key":"2026090707080285300_cit28","doi-asserted-by":"publisher","first-page":"39297","DOI":"10.1039\/D4RA06992G","article-title":"Cancer treatment approaches within\nthe frame of hyperthermia, drug delivery systems, and biosensors:\nconcepts and future potentials","volume":"14","author":"Sayed","year":"2024","journal-title":"RSC Adv."},{"issue":"24","key":"2026090707080285300_cit29","first-page":"6950","article-title":"Efficacy of liposomes and hyperthermia\nin a human tumor xenograft model: importance of triggered drug release","volume":"60","author":"Kong","year":"2000","journal-title":"Cancer Res."},{"issue":"4374","key":"2026090707080285300_cit30","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1126\/science.364652","article-title":"Design of\nliposomes for enhanced local release of drugs by hyperthermia","volume":"202","author":"Yatvin","year":"1978","journal-title":"Science"},{"key":"2026090707080285300_cit31","doi-asserted-by":"publisher","first-page":"119527","DOI":"10.1016\/j.lfs.2021.119527","article-title":"A comprehensive review on time-tested anticancer drug\ndoxorubicin","volume":"278","author":"Sritharan","year":"2021","journal-title":"Life Sci."},{"issue":"4","key":"2026090707080285300_cit32","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.3390\/molecules28041864","article-title":"Preparation and Evaluation of Thermosensitive Liposomes Encapsulating\nI-125-Labeled Doxorubicin Derivatives for Auger Electron Therapy","volume":"28","author":"Elghobary","year":"2023","journal-title":"Molecules"},{"issue":"5","key":"2026090707080285300_cit33","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1021\/ja8086664","article-title":"Silver-mediated\nfluorination of functionalized\naryl stannanes","volume":"131","author":"Furuya","year":"2009","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"2026090707080285300_cit34","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1111\/j.1349-7006.2009.01279.x","article-title":"Evaluation\nof radioiodinated vesamicol analogs for sigma receptor imaging in\ntumor and radionuclide receptor therapy","volume":"100","author":"Ogawa","year":"2009","journal-title":"Cancer\nSci."},{"key":"2026090707080285300_cit35","doi-asserted-by":"publisher","first-page":"102402","DOI":"10.1016\/j.pdpdt.2021.102402","article-title":"Electrostatically self-assembled\ngold nanorods with chondroitin sulfate for targeted photothermal therapy\nfor melanoma","volume":"35","author":"Sano","year":"2021","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"11","key":"2026090707080285300_cit36","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1021\/acs.molpharmaceut.4c00732","article-title":"Development of Radiolabeled Probes\nwith Improved Imaging Contrast\nby Releasing Urinary Excretable Radiolabeled Compounds from Thermosensitive\nLiposomes in the Blood","volume":"21","author":"Munekane","year":"2024","journal-title":"Mol. Pharmaceutics"},{"issue":"5","key":"2026090707080285300_cit37","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3390\/molecules30051038","article-title":"An Evaluation of the\nPotential Radiosensitization Effect of Spherical Gold Nanoparticles\nto Induce Cellular Damage Using Different Radiation Qualities","volume":"30","author":"Engelbrecht-Roberts","year":"2025","journal-title":"Molecules"},{"issue":"16","key":"2026090707080285300_cit38","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.3390\/ijms23169434","article-title":"Comparison\nof the Therapeutic Effects of [211At]NaAt and\n[131I]NaI in an NIS-Expressing Thyroid Cancer Mouse Model","volume":"23","author":"Watabe","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"2026090707080285300_cit39","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1016\/j.bmc.2019.06.046","article-title":"Synthesis of an amphiphilic\ntetrazine derivative and its application\nas a liposomal component to accelerate release of encapsulated drugs","volume":"27","author":"Kannaka","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"2026090707080285300_cit40","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1021\/acs.molpharmaceut.1c00936","article-title":"Enhanced Therapeutic Effect of Liposomal\nDoxorubicin via Bio-Orthogonal\nChemical Reactions in Tumors","volume":"19","author":"Kannaka","year":"2022","journal-title":"Mol. Pharmaceutics"},{"issue":"9","key":"2026090707080285300_cit41","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1021\/acs.molpharmaceut.8b00441","article-title":"Enhanced Delivery of\nRadiolabeled Polyoxazoline into Tumors via Self-Aggregation under\nHyperthermic Conditions","volume":"15","author":"Sano","year":"2018","journal-title":"Mol. Pharmaceutics"},{"issue":"2","key":"2026090707080285300_cit42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0022-2836(91)90203-I","article-title":"DNA-drug interactions.\nThe crystal structures of d(TGTACA) and d(TGATCA) complexed with daunomycin","volume":"222","author":"Nunn","year":"1991","journal-title":"J. Mol. Biol."},{"issue":"5","key":"2026090707080285300_cit43","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00418-020-01857-x","article-title":"Detection\nof doxorubicin, cisplatin and therapeutic antibodies in formalin-fixed\nparaffin-embedded human cancer cells","volume":"153","author":"Bockelmann","year":"2020","journal-title":"Histochem.\nCell Biol."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.6c00443","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/9\/4681\/66244603\/acs.molpharmaceut.6c00443.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/9\/4681\/66244603\/acs.molpharmaceut.6c00443.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:29:38Z","timestamp":1788780578000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/23\/9\/4681\/5231636\/Auger-Electron-Therapy-Enhanced-by-Heat-Triggered"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,7,24]]},"published-print":{"date-parts":[[2026,9,7]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6c00443","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]}}}